0001474064-13-000025.txt : 20130211 0001474064-13-000025.hdr.sgml : 20130211 20130211164400 ACCESSION NUMBER: 0001474064-13-000025 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130207 FILED AS OF DATE: 20130211 DATE AS OF CHANGE: 20130211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Selisker Rachel R CENTRAL INDEX KEY: 0001313793 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23272 FILM NUMBER: 13592314 MAIL ADDRESS: STREET 1: 550 HILLS DRIVE STREET 2: 3RD FLOOR CITY: BEDMINSTER STATE: NJ ZIP: 07921 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000890465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 870439579 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 BUSINESS PHONE: (908) 450-5300 MAIL ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2013-02-07 0000890465 NPS PHARMACEUTICALS INC NPSP 0001313793 Selisker Rachel R 550 HILLS DRIVE BEDMINSTER NJ 07921 1 0 0 0 Common stock 2013-02-07 4 J 0 15225 A 15225 D Common stock 2013-02-07 4 S 0 5325 8.74 D 9900 D Shares acquired upon vesting of restricted stock units granted to the Reporting Person on February 7, 2012 and reported on a Form 4 filed on February 9, 2012. The Reporting Person reported all restricted stock units granted to the Reporting Person on February 7, 2012 in Table I of the Form 4 filed on February 9, 2012. As such, no adjustment to the Reporting Person's beneficial ownership needs to be made to reflect this vesting event. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2012. /s/ Edward Stratemeier as Attorney-in-Fact 2013-02-11